Rockwell Medical (RMTI) Gross Margin (2010 - 2026)
Rockwell Medical (RMTI) posted Gross Margin of 16.71% for Q1 2026, down 20.94% on a QoQ basis from 21.14% in Q4 2025, and up 63.0% year-over-year from 10.25% in Q1 2025.
Rockwell Medical (RMTI) Gross Margin (2010 - 2026) Analysis & Trends
Rockwell Medical's Gross Margin history runs 17 years deep, the most recent figure standing at 16.71% for Q1 2026.
- Quarterly Gross Margin rose 63.0% year-over-year to 16.71% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.07% (down 80.0% YoY) and the FY2025 annual result came in at 16.89%, down 34.0% from the prior year.
- Gross Margin was 16.71% for Q1 2026 at Rockwell Medical, down from 21.14% in the prior quarter.
- Across five years, Gross Margin topped out at 22.03% in Q3 2024 and bottomed at 4.87% in Q1 2022.
- A 5-year average of 12.56% and a median of 13.51% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin jumped 2667 bps — and 2025, when it tumbled 777 bps.
- Rockwell Medical's Gross Margin stood at 12.12% in 2022, then rose by 7 bps to 12.99% in 2023, then grew by 13 bps to 14.72% in 2024, then soared by 44 bps to 21.14% in 2025, then declined by 21 bps to 16.71% in 2026.
- Business Quant data shows RMTI's Gross Margin at 16.71% in Q1 2026, 21.14% in Q4 2025, and 14.27% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 16.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.71% |
| Dec 31, 2025 | 21.14% |
| Sep 30, 2025 | 14.27% |
| Jun 30, 2025 | 15.57% |
| Mar 31, 2025 | 16.08% |
| Dec 31, 2024 | 14.72% |
| Sep 30, 2024 | 22.03% |
| Jun 30, 2024 | 17.61% |
| Mar 31, 2024 | 13.51% |
| Dec 31, 2023 | 12.99% |
| Sep 30, 2023 | 9.26% |
| Jun 30, 2023 | 5.71% |
| Mar 31, 2023 | 13.21% |
| Dec 31, 2022 | 12.12% |
| Sep 30, 2022 | 4.16% |
| Jun 30, 2022 | 9.34% |
| Mar 31, 2022 | -4.87% |
| Dec 31, 2021 | -14.55% |
| Sep 30, 2021 | -2.06% |
| Jun 30, 2021 | -1.73% |